Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone marrow-derived cell research for bone and cartilage repair and osteoarthritis
NL-OMON43408Recruiting
- Sponsor
- Orthopaedie
- Start
- Aug 2016
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of bone marrow-derived mesenchymal stem cells in cartilage defect, Bone defect and osteoarthritis (OA), sponsored by Orthopaedie. Primary endpoints: Cell characterization by FACS, Capacity to form bone or cartilage and 1 more. Started Aug 2016; status: recruiting.
02
Drugs
bone marrow-derived mesenchymal stem cells
03
Conditions
cartilage defectBone defectosteoarthritis (OA)
Beyond the preview
Go deeper on NL-OMON43408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43408.